|(S)-1-(3-氟-4-(三氟甲氧基)苯基)-3-(1-(2-甲基丁酰基)哌啶-4-基)脲|CsnPharm

CAS No.: 1809885-32-2

EC5026 Catalog No. CSN25271

Synonyms: BPN-19186

EC5026 is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids.

规格	价格	促销价格	库存	数量

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

加入购物车大规格询价

加入收藏

产品咨询

400-920-2911

sales@csnpharm.cn

tech@csnpharm.cn

纯度 & 质量文件批次:

靶点选择性

生物活性

实验方案

技术信息

生物活性

描述Soluble Epoxide Hydrolase (sEH) is a key regulatory enzyme involved in the metabolism of membrane fatty acids. Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators. EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits sEH to treat pain. EC5026 has already shown efficacy for treating pain with no addictive effects or apparent adverse in laboratory animals and relieving naturally occurring pain in dogs, cats and horses^[1].
参考文献

[1] EicOsis Announces FDA Acceptance of IND Application for EC5026, the First Soluble Epoxide Hydrolase Inhibitor to Treat Pain

实验方案

计算器摩尔计算器总药量计算器工作液计算器
储存液制备
- 1 mg
- 5 mg
- 10 mg
- 1 mM
- 2.4668 mL
- 12.3339 mL
- 24.6678 mL
- 5 mM
- 0.4934 mL
- 2.4668 mL
- 4.9336 mL
- 10 mM
- 0.2467 mL
- 1.2334 mL
- 2.4668 mL

技术信息

CAS号

1809885-32-2

储存条件

粉末: Sealed in dry,2-8°C

液体: -20°C:3-6 月 -80°C:12月

分子式

C18H23F4N3O3

运输

蓝冰

分子量

405.39

别名

BPN-19186

溶解度

DMSO	250.0 mg/mL (616.7 mM)

动物实验配方

大规格询价

号为必填项

姓名: 邮箱: 手机号:

留言:

提交

EC5026 Catalog No. CSN25271

靶点选择性

请登录您的专属账户

确认信息